Cargando…
Stroke Prevention in Atrial Fibrillation and Valvular Heart Disease
There is a clinically staggering burden of disease stemming from cerebrovascular events, of which a majority are ischemic in nature and many are precipitated by atrial fibrillation (AF). AF can occur in isolation or in association with myocardial or structural heart disease. In the latter case, and...
Autores principales: | Ahmad, Saad, Wilt, Heath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897010/ https://www.ncbi.nlm.nih.gov/pubmed/27347228 http://dx.doi.org/10.2174/1874192401610010110 |
Ejemplares similares
-
Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
por: Samaras, Athanasios, et al.
Publicado: (2021) -
Practical Issues to Prevent Stroke Associated with Non-valvular Atrial Fibrillation
por: Kim, Chi Kyung, et al.
Publicado: (2013) -
Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia
por: Hersi, Ahmad S., et al.
Publicado: (2019) -
Economic Evaluation of Apixaban for the Prevention of Stroke in Non-Valvular Atrial Fibrillation in the Netherlands
por: Stevanović, Jelena, et al.
Publicado: (2014) -
Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease
por: Chen, Jian-Qin, et al.
Publicado: (2023)